Total Payments
$2.9M
2024 Payments
$349,199
Companies
10
Transactions
48
Medicare Patients
76
Medicare Billing
$8,606
Payment Breakdown by Category
Other$1.7M (57.7%)
Consulting$1.2M (41.8%)
Travel$8,522 (0.3%)
Food & Beverage$3,728 (0.1%)
Gifts$1,448 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1.2M | 5 | 41.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $693,946 | 7 | 24.1% |
| Current or prospective ownership or investment interest | $651,954 | 2 | 22.6% |
| Grant | $317,371 | 1 | 11.0% |
| Travel and Lodging | $8,522 | 13 | 0.3% |
| Food and Beverage | $3,728 | 17 | 0.1% |
| Gift | $1,448 | 2 | 0.1% |
| Entertainment | $12.62 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dexcom, Inc. | $2.8M | 27 | $0 (2024) |
| Biosense Webster, Inc. | $50,585 | 2 | $0 (2018) |
| Illumina, Inc. | $48,075 | 9 | $0 (2023) |
| Genentech USA, Inc. | $5,598 | 3 | $0 (2024) |
| Cue Health Inc. | $866.50 | 1 | $0 (2022) |
| BOSTON SCIENTIFIC CORPORATION | $400.00 | 1 | $0 (2021) |
| ASAHI INTECC USA, INC. | $213.12 | 2 | $0 (2024) |
| Abbott Laboratories | $124.72 | 1 | $0 (2017) |
| The Spectranetics Corporation | $110.41 | 1 | $0 (2017) |
| Acist Medical Systems, Inc. | $25.00 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $349,199 | 10 | Dexcom, Inc. ($343,388) |
| 2023 | $492,714 | 7 | Dexcom, Inc. ($469,724) |
| 2022 | $343,323 | 9 | Dexcom, Inc. ($317,371) |
| 2021 | $314,806 | 3 | DEXCOM, INC. ($314,381) |
| 2020 | $338,055 | 2 | Dexcom, Inc. ($338,055) |
| 2019 | $337,353 | 4 | Dexcom, Inc. ($337,353) |
| 2018 | $393,645 | 7 | Dexcom, Inc. ($343,060) |
| 2017 | $313,124 | 6 | Dexcom, Inc. ($312,889) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Dexcom, Inc. | — | Food and Beverage | In-kind items and services | $350.00 | General |
| 12/03/2024 | ASAHI INTECC USA, INC. | PERIPHERAL VASCULAR (Device) | Food and Beverage | Cash or cash equivalent | $167.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/02/2024 | ASAHI INTECC USA, INC. | PERIPHERAL VASCULAR (Device) | Food and Beverage | Cash or cash equivalent | $45.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/29/2024 | Genentech USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| 10/29/2024 | Genentech USA, Inc. | — | Travel and Lodging | Cash or cash equivalent | $564.79 | General |
| 10/29/2024 | Genentech USA, Inc. | — | Food and Beverage | Cash or cash equivalent | $33.34 | General |
| 08/16/2024 | Dexcom, Inc. | — | Food and Beverage | In-kind items and services | $410.00 | General |
| 05/24/2024 | Dexcom, Inc. | — | Food and Beverage | In-kind items and services | $490.00 | General |
| 05/22/2024 | Dexcom, Inc. | — | Consulting Fee | In-kind items and services | $341,727.54 | General |
| 03/01/2024 | Dexcom, Inc. | — | Food and Beverage | In-kind items and services | $410.00 | General |
| 12/26/2023 | Dexcom, Inc. | — | Food and Beverage | In-kind items and services | $250.00 | General |
| 12/23/2023 | Dexcom, Inc. | — | Consulting Fee | Stock, stock option, or any other ownership interest | $468,663.73 | General |
| 08/25/2023 | Dexcom, Inc. | — | Food and Beverage | In-kind items and services | $230.00 | General |
| 05/17/2023 | Dexcom, Inc. | — | Food and Beverage | In-kind items and services | $270.00 | General |
| 05/05/2023 | Illumina, Inc. | Infectious Disease (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,613.00 | General |
| Category: Genetics | ||||||
| 03/17/2023 | Illumina, Inc. | Infectious Disease (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $13,377.00 | General |
| Category: Genetics | ||||||
| 03/10/2023 | Dexcom, Inc. | — | Food and Beverage | In-kind items and services | $310.00 | General |
| 10/01/2022 | Illumina, Inc. | NovaSeq 6000Dx Sequencer Instrument (Device) | Gift | Cash or cash equivalent | $581.25 | General |
| Category: Genetics | ||||||
| 10/01/2022 | Illumina, Inc. | NovaSeq 6000Dx Sequencer Instrument (Device) | Food and Beverage | Cash or cash equivalent | $57.56 | General |
| Category: Genetics | ||||||
| 10/01/2022 | Illumina, Inc. | NovaSeq 6000Dx Sequencer Instrument (Device) | Entertainment | Cash or cash equivalent | $12.62 | General |
| Category: Genetics | ||||||
| 09/30/2022 | Illumina, Inc. | NovaSeq 6000Dx Sequencer Instrument (Device) | Food and Beverage | Cash or cash equivalent | $292.80 | General |
| Category: Genetics | ||||||
| 09/29/2022 | Illumina, Inc. | NovaSeq 6000Dx Sequencer Instrument (Device) | Food and Beverage | Cash or cash equivalent | $151.09 | General |
| Category: Genetics | ||||||
| 08/15/2022 | Illumina, Inc. | NovaSeq 6000Dx Sequencer Instrument (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $11,490.00 | General |
| Category: Devices | ||||||
| 05/20/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Grant | Cash or cash equivalent | $317,371.29 | General |
| Category: Endocrinology | ||||||
| 05/10/2022 | Illumina, Inc. | NovaSeq 6000Dx Sequencer Instrument (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $12,500.00 | General |
| Category: Devices | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 25 | 29 | $10,159 | $2,632 |
| 2022 | 1 | 31 | 34 | $11,912 | $3,168 |
| 2021 | 1 | 20 | 26 | $9,118 | $2,806 |
Total Patients
76
Total Services
89
Medicare Billing
$8,606
Procedure Codes
3
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 29 | $10,159 | $2,632 | 25.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 34 | $11,912 | $3,168 | 26.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 26 | $9,118 | $2,806 | 30.8% |
About Dr. Eric Topol, M.D
Dr. Eric Topol, M.D is a Cardiovascular Disease healthcare provider based in La Jolla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487723714.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Topol, M.D has received a total of $2.9M in payments from pharmaceutical and medical device companies, with $349,199 received in 2024. These payments were reported across 48 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($1.2M).
As a Medicare-enrolled provider, Topol has provided services to 76 Medicare beneficiaries, totaling 89 services with total Medicare billing of $8,606. Data is available for 3 years (2021–2023), covering 3 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location La Jolla, CA
- Active Since 11/08/2006
- Last Updated 11/22/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1487723714
Products in Payments
- Dexcom CGM (Device) $343,060
- DEXCOM G6 CGM SYSTEM (Device) $338,055
- DEXCOM CGM (Device) $337,353
- Dexcom G6 Transmitter (Medical Supply) $317,371
- DEXCOM G6 TRANSMITTER (Device) $314,381
- Dexcom G5 Mobile CGM System (Device) $312,889
- PENTARAY (Device) $50,000
- NovaSeq 6000Dx Sequencer Instrument (Device) $25,085
- Infectious Disease (Device) $22,990
- Cue Health Monitoring System (Device) $866.50
- Pentaray (Device) $585.00
- GENERAL THERAPIES (Device) $400.00
- PERIPHERAL VASCULAR (Device) $213.12
- Mitra Clip system (Device) $124.72
- ELCAELCA X-80 (Device) $110.41
- HD-IVUS (Device) $25.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in La Jolla
Dr. James Heywood, M.d, M.D
Cardiovascular Disease — Payments: $1.7M
Cardiovascular Disease $1.7M
Dr. Douglas Gibson, M.d,, M.D,
Cardiovascular Disease — Payments: $742,202
Cardiovascular Disease $742,202
Dr. Paul Teirstein, M.d, M.D
Cardiovascular Disease — Payments: $562,019
Cardiovascular Disease $562,019
Dr. Douglas Triffon, M.d, M.D
Cardiovascular Disease — Payments: $416,661
Cardiovascular Disease $416,661
Dr. Richard Schatz, M.d, M.D
Cardiovascular Disease — Payments: $140,725
Cardiovascular Disease $140,725
George Mendenhall, Md, MD
Cardiovascular Disease — Payments: $103,711
Cardiovascular Disease $103,711